Psychiatric outcomes 10 years after treatment with antidepressants or anxiolytics

British Journal of Psychiatry

Volumn 193, Issue 4, 2008, Pages 327-331

  Colman, Ian ^a   Croudace, Tim J ^b   Wadsworth, Michael E J ^c   Kuh, Diana ^c   Jones, Peter B ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT;

ADULT; ALCOHOL ABUSE; ANXIETY; ARTICLE; DEPRESSION; DRUG EFFICACY; HELP SEEKING BEHAVIOR; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MENTAL DISEASE; PREVALENCE; PSYCHIATRIC TREATMENT; SLEEP DISORDER; STATISTICAL ANALYSIS; SUICIDAL IDEATION; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; DRUG THERAPY, COMBINATION; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 53949100242     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.107.043430     Document Type: Article

References (31)

1. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell w, Paulus MP, Kunovac JL, Leon AC, Mueller Tl, Rice JA, Keller MB. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998; 55: 694-700.
2. Merikangas KR, Zhang H, Avenevoli S, Acharyya S, Neuenschwander M, Angst J Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch Gen Psychiatry 2003; 60: 993-1000.
3. Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003; 361: 653-61.
4. Leon AC, Solomon DA, Mueller Tl, Endicott J, Rice JP, Maser JD, Coryell W, Keller MB. A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry 2003; 160: 727-33.
5. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70: 41-55.
6. Wadsworth ME, Butterworth SL, Hardy RJ, Kuh DJ, Richards M, Langenberg C, Hilder WS, Connor M. The life course prospective design: an example of benefits and problems associated with study longevity. Soc Sci Med 2003; 57: 2193-205.
7. Lindelow M, Hardy R, Rodgers B. Development of a scale to measure symptoms of anxiety and depression in the general UK population: the psychiatric symptom frequency scale. J Epidemiol Community Health 1997; 51: 549-57.
8. Paykel ES, Hayhurst H, Abbott R, Wadsworth M. Stability and change in milder psychiatric disorder over 7 years in a birth cohort. Psychol Med 2001; 31: 1373-84.
9. British Medical Association and Royal Pharmaceutical Society of Great Britain. British 10 National Formulary Number 44. BMJ Group and RPS Publishing Group, 2002.
10. Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med 1979; 9: 139-45.
11. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA 1984; 252: 1905-7.
12. Bebbington PE, Nayani T. The psychosis screening questionnaire. Int J Methods Psychiatr Res 1998; 5: 11-20.
13. Keller MB, Lavoti PW, Mueller Tl, Endicott J, Coryell W, Hirschfeld RM, Shea T. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992; 49: 809-16.
14. Seivewright H, Tyrer p, Johnson T. Prediction of outcome in neurotic disorder: a 5-year prospective study. Psychol Med 1998; 28: 1149-57.
15. Mueller Tl, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, warshaw M, Maser JD. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry 1999; 156: 1000-6.
16. Colman I, Croudace TJ, wadsworth ME, Jones PB. Factors associated with antidepressant anxiolytic and hypnotic use over 17 years in a national cohort. J Affect Disord 2008 in press.
17. Wing K, Cooper je, Sartorius N. The Measurement and Classification of Psychiatric Symptoms. Cambridge University Press, 1974.
18. Wing JK, Mann SA, Leff JP, Nixon JM. The concept of a 'case' in psychiatric population surveys. Psychol Med 1978; 8: 203-17.
19. Paykel ES, Watters L, Abbott R, Wadsworth M. Do treated psychiatric patients become later community cases? A prospective cohort study. Eur Psychiatry 2006; 21: 315-8.
20. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9). WHO, 1978.
21. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-10). WHO, 1999.
22. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Star Med 1998; 17: 2265-81.
23. Pintor L, Gasto C, Navarro V, Torres X, Fananas L. Relapse of major depression after complete and partial remission during a 2-year follow-up. J Affect Disord 2003; 73: 237-44.
24. Ellis PM, Smith DA. Treating depression: the beyondblue guidelines for treating depression in primary care. 'Not so much what you do but that you keep doing it'. Med J Aust 2002; 176 (suppl 40): S77-83.
25. Colman I, Wadsworth ME, Croudace TJ, Jones PB. Three decades of antidepressam, anxiolytic and hypnotic use in a national population birth cohort. Br J Psychiatry 2006; 189: 156-60.
26. Burns T, Eichenberger A, Eich D, Ajdacic-Gross V, Angst J, Rossler W. Which individuals with affective symptoms seek help? Results from the Zurich epidemiological study. Acta Psychiatr Scand 2003; 108: 419-26.
27. Jorm AF, Christensen H, Medway J, Korten AE, Jacomb PA, Rodgers B. Public belief systems about the helpfulness of interventions for depression: associations with history of depression and professional help-seeking. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 211-9.
28. Jorm AF, Medway J, Christensen H, Korten AE, Jacomb PA, Rodgers B. Public beliefs about the helpfulness of interventions for depression: effects on actions taken when experiencing anxiety and depression symptoms. Aust N Z J Psychiatry 2000; 34: 619-26.
29. Simon GE, Goldberg D, Tiemens BG, Ustun TB. Outcomes of recognized and unrecognized depression in an international primary care study. Gen Hosp Psychiatry 1999; 21: 97-105.
30. Andrews G, Issakidis C, Carter G. Shortfall in mental health service utilisation. Br J Psychiatry 2001; 179: 417-25.
31. Simon GE, Fleck M, Lucas R, Bushnell DM. Prevalence and predictors of depression treatment in an international primary care study. Am J Psychiatry 2004; 161: 1626-34.